Últimas noticias sobre Signing Day Sports (AMEX:SGN) Bolsa

Signing Day Sports

Signing Day Sports Inc is a technology company developing and operating platforms aiming to allow significantly more student-athletes to go to college and continue playing sports. Its platform Signing Day Sports is a digital ecosystem to help athletes get discovered and recruited by coaches and recruiters across the country. It currently fully supports football and baseball, and it plans to expand the Signing Day Sports platform to include additional sports.

Signing Day Sports Inc

StemGen Inc

Signal Gold Inc

News

TZUP

Thumzup Board Approves Purchase Of Up To $1M In Bitcoin

AIM ImmunoTech (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AIM#AMEX">AIM</a>) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.12) by 50 percent. The company reported quarterly sales of $35.00 thousand which missed the analyst consensus estimate of $67.50 thousand by 48.15 percent. This is a 23.91 percent decrease over sales of $46.00 thousand the same period last year.

Earnings

AIM ImmunoTech Q3 2024 GAAP EPS $(0.06) Beats $(0.12) Estimate, Sales $35.00K Miss $67.50K Estimate

FCEL

FuelCell Energy Announces Global Restructuring, Focusing Core Technologies On Distributed Power Generation: Company To Reduce Total Operating Costs By An Estimated 15% In Fiscal Year 2025

Nexxen International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXN#NASDAQ">NEXN</a>) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.11 by 27.27 percent. The company reported quarterly sales of $90.200 million which beat the analyst consensus estimate of $87.125 million by 3.53 percent. This is a 12.62 percent increase over sales of $80.094 million the same period last year.

Earnings Beats

NEXN

Nexxen International Q3 2024 Adj. EPS $0.14 Beats $0.11 Estimate, Sales $90.200M Beat $87.125M Estimate

Three Midwest cities are emerging as affordable housing havens, requiring much less than the typical six-figure salary <a href="https://www.benzinga.com/economics/macro-economic-events/24/07/39614880/now-owning-a-house-in-us-is-more-challenging-than-ever-as-affordability-drops-to-">needed for homeownership in many U.S. markets</a>. Rockford, Illinois; Akron, Ohio; and Canton, Ohio, have secured spots among Realtor.com's top 20 hottest housing markets, offering median home prices around $250,000 – well below the national median of $424,950.
Don't Miss:
<ul>
<li>This Jeff Bezos-backed startup will allow you to<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> become a landlord in just 10 minutes and you only need $100</a>.</li>
<li>This company is giving accredited investors an opportunity to invest in this $2 billion fund, <a href="https://www.benzinga.com/money/ignite-funding">with three decades in business they boast an impressive track record of double-digit returns.</a></li>
</ul>
&#8220;The typical [monthly] mortgage payment, assuming a 10% down payment, would be $1,455 or less in these areas,&#8221; reports Hannah Jones, senior economic research analyst at Realtor.com. &#8220;Including tax and insurance costs, the minimum recommended income to afford this payment is roughly $73,000, about 10% less than the national median household income.&#8221;
Rockford, Illinois, leads the group with a median list price of $242,000, attracting buyers with its proximity to Chicago and Milwaukee. Local real estate agent David Dale Johnson of Berkshire Hathaway HomeServices told Realtor.com that his market has had strong activity. &#8220;Inventory levels are still low in Rockford," he said. "Some areas of the Rockford market still see full price or greater offers.&#8221;
Trending: During market downturns, investors are learning that unlike equities, these<a href="https://www.benzinga.com/money/connect-invest-real-estate-notes"> high-yield real estate notes that pay 7.5% – 9% are protected by resilient assets, buffering against losses.</a>
Akron, Ohio – the birthplace of NBA superstar LeBron James – presents an attractive option at $228,000. Homes sell in just 36 days, 22 days faster than the national average. The city&#8217;s appeal extends beyond affordability, according to Gregg Mervis, president of the Akron/Summit Convention &amp; Visitors Bureau. &#8220;Greater Akron is an exceptional location that blends urban excitement with natural beauty.&#8221;
Canton, Ohio, with a median price of $252,000, recently topped the Wall Street Journal/Realtor.com Housing Market Ranking. Local expert Paul Gabrail told Realtor.com there is an investment opportunity in the area. &#8220;In terms of ROI, if you can buy a property for a relatively low price while the nation&#8217;s income goes up, you&#8217;ll probably do better in cities like Canton versus bigger cities in the West,&#8221; he said.
See Also: ‘Beating the market through ethical real estate investing' –<a href="https://www.benzinga.com/money/invest-with-roots"> this platform aims to give tenants equity in the homes they live in while scoring 17.38% average annual returns for investors – here&#8217;s how to join with just $100</a>
These Midwestern markets offer unique advantages beyond price points. Rockford provides free college tuition at Northern Illinois University for qualified residents, while Akron has strong climate resilience with just 1.8% of properties at risk of natural disasters over the next 30 years. Realtor.com noted that Canton's status as the birthplace of the NFL and home to the Pro Football Hall of Fame adds cultural significance to its economic appeal.
The continued strength of these markets, consistently ranking since February 2022, suggests a sustainable trend rather than a temporary shift. Their affordability, quality of life and economic opportunity make them viable alternatives <a href="https://www.benzinga.com/real-estate/24/11/41876775/u-s-homebuyers-are-now-56-on-average-as-younger-generations-struggle-with-wildly-unaffordable-market-housing-expert-warns">for homebuyers priced out of larger metropolitan areas</a>.
Read Next:
<ul>
<li>Unlock the hidden potential of commercial real estate –<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> This platform allows individuals to invest in commercial real estate offering a 12% target yield with a bonus 1% return boost today!</a></li>
<li>These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"> they all believe in one platform that offers a 7-9% target yield with monthly dividends</a></li>
</ul>

Real Estate

You Don't Need A $100K Salary To Afford A Mortgage In These 3 Livable Cities – Unsurprisingly, In The Midwest

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth reiterates Leap Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPTX#NASDAQ">LPTX</a>) with a Buy and maintains $5.5 price target.

Price Target

Reiteration

Analyst Ratings

LPTX

HC Wainwright & Co. Reiterates Buy on Leap Therapeutics, Maintains $5.5 Price Target

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth reiterates Affimed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFMD#NASDAQ">AFMD</a>) with a Buy and maintains $10 price target.

AFMD

HC Wainwright & Co. Reiterates Buy on Affimed, Maintains $10 Price Target

UBS analyst Laura Sutcliffe initiates coverage on Telix Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLX#NASDAQ">TLX</a>) with a Buy rating and announces Price Target of $21.

Initiation

UBS Initiates Coverage On Telix Pharmaceuticals with Buy Rating, Announces Price Target of $21

HC Wainwright &amp; Co. analyst Emily Bodnar maintains Genelux (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLX#NASDAQ">GNLX</a>) with a Buy and lowers the price target from $32 to $30.

GNLX

HC Wainwright & Co. Maintains Buy on Genelux, Lowers Price Target to $30

BMO Capital analyst John Kim upgrades Independence Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IRT#NYSE">IRT</a>) from Underperform to Market Perform and raises the price target from $19 to $21.

Upgrades

BMO Capital Upgrades Independence Realty Trust to Market Perform, Raises Price Target to $21

EYEN

Trading Halt: Halt status updated at 7:25:00 AM ET: Quotation Resumption: News and Resumption Times

WIIM

POOL

Pool Corp shares are trading higher after a 13F filing showed that Berkshire Hathaway added a new stake.

Domino's Pizza shares are trading higher after a 13F filing showed that Berkshire Hathaway added a new stake.

Baird analyst Shrenik Kothari maintains Palo Alto Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) with a Outperform and raises the price target from $385 to $425.

PANW

Baird Maintains Outperform on Palo Alto Networks, Raises Price Target to $425

ULTA

Ulta Beauty shares are trading lower after Berkshire Hathaway cut its position in the stock.

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates TransCode Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) with a Buy and maintains $3 price target.

RNAZ

HC Wainwright & Co. Reiterates Buy on TransCode Therapeutics, Maintains $3 Price Target

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/66585980a3067c00012c48c0/david-roman">Goldman Sachs analyst David Roman </a>initiated coverage on HealthEquity, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HQY#NASDAQ">HQY</a>) with a Neutral rating and announced a price target of $108. HealthEquity shares closed at $95.70 on Thursday. <a href="https://www.benzinga.com/quote/HQY/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Wolfe Research analyst Alexandria Hammond initiated coverage on Pfizer Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) with an Underperform rating and announced a price target of $25. Pfizer shares closed at $26.02 on Thursday. <a href="https://www.benzinga.com/quote/PFE/analyst-ratings">See how other analysts view this stock.</a></li>
<li><a href="https://www.benzinga.com/insights/analyst-ratings/24/10/41494343/analyst-expectations-for-mastecs-future">Stifel analyst Brian Brophy</a> initiated coverage on EMCOR Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EME#NYSE">EME</a>) with a Buy rating and announced a price target of $600. EMCOR shares closed at $498.11 on Thursday. <a href="https://www.benzinga.com/quote/EME/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Redburn Atlantic analyst Harry Read initiated coverage on Insight Enterprises, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSIT#NASDAQ">NSIT</a>) with a Buy rating and announced a price target of $220. Insight Enterprises shares closed at $152.63 on Thursday. See how other analysts view this stock.</li>
<li>Wolfe Research analyst Alexandria Hammond initiated coverage on Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) with an Outperform rating and announced a price target of $190. Johnson &amp; Johnson shares closed at $151.87 on Thursday. <a href="https://www.benzinga.com/quote/JNJ/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying JNJ stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="569" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/15072028/image-169-1024x569.png" alt="" class="wp-image-650063" style="width:716px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/15072028/image-169-1024x569.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/15072028/image-169-300x167.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/15072028/image-169-768x427.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/15072028/image-169.png 1196w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/42000528/dow-dips-over-200-points-following-economic-reports-tesla-tumbles-on-potential-removal-of-ev-tax-credit-fear-index-remains-in-greed-zone">Dow Dips Over 200 Points Following Economic Reports, Tesla Tumbles On Potential Removal Of EV Tax Credit: Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>

Pre-Market Outlook

Markets

Trading Ideas

NSIT

This Johnson & Johnson Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Sol-Gel Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLGL#NASDAQ">SLGL</a>) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.13) by 92.31 percent. This is a 95.24 percent increase over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $5.36 million which beat the analyst consensus estimate of $2.69 million by 99.29 percent. This is a 2.42K percent increase over sales of $213.00 thousand the same period last year.

SLGL

Sol-Gel Technologies Q3 EPS $(0.01) Beats $(0.13) Estimate, Sales $5.36M Beat $2.69M Estimate

Baird analyst Wesley Golladay maintains Kite Realty Gr Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRG#NYSE">KRG</a>) with a Neutral and raises the price target from $26 to $29.

Baird Maintains Neutral on Kite Realty Gr Trust, Raises Price Target to $29

HC Wainwright &amp; Co. analyst Arthur He reiterates Poseida Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTX#NASDAQ">PSTX</a>) with a Buy and maintains $20 price target.

PSTX

HC Wainwright & Co. Reiterates Buy on Poseida Therapeutics, Maintains $20 Price Target

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Signing Day Sports (NYSEMKT:<a href="https://investorplace.com/stock-quotes/sgn-stock-quote/">SGN</a>) just reported results for the second quarter of 2024.<ul><li>Signing Day Sports reported earnings per share of 25 cents.</li><li>The company reported revenue of $439,589.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div>	The post <a href="https://investorplace.com/earning-results/2024/08/sgn-stock-earnings-signing-day-sports-for-q2-of-2024/">SGN Stock Earnings: Signing Day Sports Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

SGN Stock Earnings: Signing Day Sports Reported Results for Q2 2024

Signing Day Sports announces 1-for-48 reverse split

Signing Day Sports, Inc. ( ($SGN) ) has shared an announcement. Signing Day Sports, Inc. announced a 1-for-48 reverse stock split, effective Novemb...

Signing Day Sports Implements Reverse Stock Split Strategy

Signing Day Sports (SGN) announced that it will effect a 1-for-48 reverse stock split of its shares of common stock that will become effective on N...

Signing Day Sports to effect 1-for-48 reverse stock split

Signing Day Sports, Inc. ( ($SGN) ) has issued an update. Signing Day Sports has extended its timeline to acquire Dear Cashmere Group, doing busine...

Signing Day Sports Extends Acquisition Timeline for Swifty

Signing Day Sports (SGN) provided an update on the process to close on the recently announced transaction to acquire Dear Cashmere, doing business ...

Signing Day Sports reports progress on planned acquisition of Swifty Global

Walt Disney, Cisco, And Shopify Headline Latest Earnings Week

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Signing Day Sports (NYSEMKT:<a href="https://investorplace.com/stock-quotes/sgn-stock-quote/">SGN</a>) just reported results for the second quarter of 2024.<ul><li>Signing Day Sports reported earnings per share of 25 cents.</li><li>The company reported revenue of $439,589.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div>	
	The post <a href="https://investorplace.com/earning-results/2024/08/sgn-stock-earnings-signing-day-sports-for-q2-of-2024/">SGN Stock Earnings: Signing Day Sports Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

AAPL

ALCN

AMAT

ANGI

ARMK

BABA

BBWI

BEKE

BTOC

CPRT

CSCO

CYBR

EVGO

EXTR

JDZG

LAZR

PAYO

REGN

RMLFF

SHOP

SPOT

STLA

TALO

TSEM

WELL

YUMC

ZETA

Press Releases

Signing Day Sports Announces Selected Financial Results for Three and Six Months Ended June 30, 2024

Signing Day Sports Signs Binding Term Sheet to Acquire Majority Equity Interest in High Growth Sports Gaming Technology Company Swifty Global

Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports

"Signing Day Sports, Inc. (NYSE American: SGN) Soars in Pre-Market on Acquisition News – see more penny stocks inside…."

Signing Day Sports Identifies Synergies from Acquisition of Swifty Global, Expected to Drive Accelerated Revenue Growth, Cost Savings, and Global Expansion

US Army Bowl National Combine Returns for 3rd Annual Event Powered by Signing Day Sports

Signing Day Sports Provides Update on Acquisition of Swifty Global

Signing Day Sports Announces 1-for-48 Reverse Split

Signing Day Sports Reports Progress on Planned Acquisition of Swifty Global

Signing Day Sports Announces Selected Financial Results for Nine and Three Months Ended September 30, 2024

Comments

Signing Day Sports

Noticias

Últimas noticias sobre Signing Day Sports (AMEX:SGN) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL